134 related articles for article (PubMed ID: 3891541)
1. One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
Grice G; Spencer RC; Steele CE; Kinghorn GR
Gynakol Rundsch; 1985; 25 Suppl 1():83-9. PubMed ID: 3891541
[No Abstract] [Full Text] [Related]
2. Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis.
Loendersloot EW
Gynakol Rundsch; 1985; 25 Suppl 1():99-104. PubMed ID: 4007627
[No Abstract] [Full Text] [Related]
3. Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
Goormans E
Gynakol Rundsch; 1985; 25 Suppl 1():74-82. PubMed ID: 3891540
[No Abstract] [Full Text] [Related]
4. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
Kjaeldgaard A
Pharmatherapeutica; 1986; 4(8):525-31. PubMed ID: 3520601
[TBL] [Abstract][Full Text] [Related]
5. Comparative open evaluation of efficacy and tolerability of terconazole 0.8% cream in a 5-day regimen versus clotrimazole 100-mg tablets in a 6-day regimen.
Wesel S; Benijts G; Ubachs JM; Dogniez B
Gynakol Rundsch; 1985; 25 Suppl 1():67-73. PubMed ID: 4007625
[No Abstract] [Full Text] [Related]
6. Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study.
Siedentopf HG
Gynakol Rundsch; 1985; 25 Suppl 1():33-41. PubMed ID: 4007622
[No Abstract] [Full Text] [Related]
7. Single-day topical treatment of vaginal candidosis: an open evaluation of terconazole 240-mg vaginal suppositories versus isoconazole tablets 600 mg.
Münnich W; Hiltl BP
Gynakol Rundsch; 1985; 25 Suppl 1():90-8. PubMed ID: 4007626
[No Abstract] [Full Text] [Related]
8. A single-blind comparison of oral and intravaginal treatments in acute and recurrent vaginal candidosis in general practice.
Miller PI; Humphries M; Grassick K
Pharmatherapeutica; 1984; 3(9):582-7. PubMed ID: 6328542
[TBL] [Abstract][Full Text] [Related]
9. [A multicenter, randomized, open and positive parallel controlled clinical study of clotrimazole vaginal expansion suppository and vaginal tablet in the treatment of mild and moderate vulvovaginal candidiasis].
Zhang L; Liao QP; Wang CH; Zhang D; An RF; Zheng JH; Wang Y; Zhang QQ; Chen R
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):697-702. PubMed ID: 33120482
[No Abstract] [Full Text] [Related]
10. Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
Delecour M
Gynakol Rundsch; 1985; 25 Suppl 1():42-51. PubMed ID: 3891538
[No Abstract] [Full Text] [Related]
11. Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis.
Adamson GD; Brown D; Standard JV; Henzl MR
J Reprod Med; 1986 Feb; 31(2):131-2. PubMed ID: 3514908
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vaginal candidosis with three 80-mg terconazole vaginal suppositories: results of a multicentre study in France.
Nahmanovici C
Gynakol Rundsch; 1985; 25 Suppl 1():52-8. PubMed ID: 3891539
[No Abstract] [Full Text] [Related]
13. The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis.
Saghafi N; Karjalian M; Ghazanfarpour M; Khorsand I; Rakhshandeh H; Mirteimouri M; Babakhanian M; Khadivzadeh T; Najafzadeh MJ; Ghorbani A; Pourali L; Bahman S
J Obstet Gynaecol; 2018 Oct; 38(7):985-988. PubMed ID: 29553834
[TBL] [Abstract][Full Text] [Related]
14. A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial.
Br J Obstet Gynaecol; 1989 Feb; 96(2):226-32. PubMed ID: 2539186
[TBL] [Abstract][Full Text] [Related]
15. Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis.
Bingham JS
Br J Vener Dis; 1984 Jun; 60(3):175-7. PubMed ID: 6329405
[TBL] [Abstract][Full Text] [Related]
16. Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories.
Litschgi M
Gynakol Rundsch; 1985; 25 Suppl 1():59-66. PubMed ID: 4007623
[No Abstract] [Full Text] [Related]
17. Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole.
Cohen L
Br J Vener Dis; 1984 Feb; 60(1):42-4. PubMed ID: 6365236
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Li T; Zhu Y; Fan S; Liu X; Xu H; Liang Y
Med Mycol; 2015 Jun; 53(5):455-61. PubMed ID: 25877666
[TBL] [Abstract][Full Text] [Related]
19. Comparison of miconazole-coated tampons with clotrimazole vaginal tablets in the treatment of vaginal candidosis.
Balsdon MJ
Br J Vener Dis; 1981 Aug; 57(4):275-8. PubMed ID: 7272707
[TBL] [Abstract][Full Text] [Related]
20. Three-day therapy of vaginal candidiasis with clotrimazole vaginal tablets and econazole ovules: a multicentre comparative study.
Benijts G; Vignalli M; Kreysing W; Stettendorf S
Curr Med Res Opin; 1980; 7(1):55-61. PubMed ID: 7428415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
